RX8-12744-13558
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 900 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-28
Registered in v-safe
-
2021-03-28
Dose 1 — Pfizer-BioNTech
-
2021-03-28
Health check-in — day 0, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-30
- 2021-04-01
- 2021-04-03
- 2021-04-13
-
2021-04-18
Dose 2 — Pfizer-BioNTech
- 2021-04-25
- 2021-05-04
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-07-20
- 2021-10-17
-
2021-12-19
Dose 3 — Pfizer-BioNTech
-
2022-04-18
Survey response — 12 months, dose 2MedDRA: COVID-19, Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Had Covid in January Had stomach flu in FebruaryMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-19
Survey response — 6 months, dose 3MedDRA: Glucose tolerance impaired — Feeling: GoodFree text: Pre-diabetesMedDRA releases: 2024-11 · check-in free text available
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | |
| 2 | 2021-04-18 | Pfizer-BioNTech | |
| 3 | 2021-12-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: Had Covid in January Had stomach flu in February
Release 12 — 6 months, dose 3
Symptoms: Pre-diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Glucose tolerance impaired | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release